About Index Trending news
Analyze
Top 50 Pricing
Xeris Pharmaceuticals

Xeris Pharmaceuticals

Work at Xeris Pharmaceuticals? Add yourself to this profile

Xeris Pharmaceuticals

Xeris Pharmaceuticals is a specialty company developing patient-friendly injectables for indications in diabetes, epilepsy, and immunology.

Elsewhere

Alexa global traffic share

Latest funding Show all
Venture capital (Series C)
$41,000,000
Redmile Group, Deerfield Management Company, Sabby Management, +1
Venture capital (Series B)
$13,000,000
Employees

Team size

2
Locations
HQ
$41,000,000 Venture capital (Series C)
FinSMEs

Xeris Pharmaceuticals Closes $41M Series C Financing

Funding Health